Structure and Bioactivity of a Modified Peptide Derived from the LPS-Binding Domain of an Anti-Lipopolysaccharide Factor (ALF) of Shrimp.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27213409)

Published in Mar Drugs on May 19, 2016

Authors

Hui Yang1,2, Shihao Li3,4, Fuhua Li5,6, Jianhai Xiang7

Author Affiliations

1: Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China. victor1900@163.com.
2: University of Chinese Academy of Sciences, Beijing 100049, China. victor1900@163.com.
3: Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China. lishihao@qdio.ac.cn.
4: Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China. lishihao@qdio.ac.cn.
5: Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China. fhli@qdio.ac.cn.
6: Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China. fhli@qdio.ac.cn.
7: Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China. jhxiang@qdio.ac.cn.

Articles cited by this

Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50

Peptide antibiotics and their role in innate immunity. Annu Rev Immunol (1995) 6.81

Cationic peptides: a new source of antibiotics. Trends Biotechnol (1998) 5.10

Mode of action of membrane active antimicrobial peptides. Biopolymers (2002) 4.74

Antibacterial peptides: basic facts and emerging concepts. J Intern Med (2003) 4.44

Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88

Amphipathic, alpha-helical antimicrobial peptides. Biopolymers (2000) 3.68

Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta (1998) 2.71

The relationship between peptide structure and antibacterial activity. Peptides (2003) 2.51

Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu Rev Microbiol (1995) 2.43

Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A (2004) 2.00

Amphipathic alpha helical antimicrobial peptides. Eur J Biochem (2001) 1.90

Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol (2006) 1.87

Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother (2006) 1.87

Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78

Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75

Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta (2008) 1.66

Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett (2001) 1.52

Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol (2011) 1.49

Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett (1997) 1.47

Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother (2005) 1.27

Host defence (cationic) peptides: what is their future clinical potential? Drugs (1999) 1.26

Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers (1998) 1.24

Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci U S A (1996) 1.17

Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides (2005) 1.16

Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides (2007) 1.16

Phytochemical and in vitro antimicrobial assay of the leaf extract of Newbouldia laevis. Afr J Tradit Complement Altern Med (2007) 1.15

Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother (2010) 1.15

Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J Biol Chem (2012) 1.14

Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry (2003) 1.13

Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie (2010) 1.07

Limulus anti-LPS factor: an anticoagulant which inhibits the endotoxin mediated activation of Limulus coagulation system. Biochem Biophys Res Commun (1982) 1.06

Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob Agents Chemother (2013) 1.03

Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. Eur J Biochem (2000) 0.96

Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J Biol Chem (1986) 0.93

Antimicrobial peptides discovered in the black tiger shrimp Penaeus monodon using the EST approach. Dis Aquat Organ (2004) 0.92

Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J Pept Res (1997) 0.91

Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli. Biochem Biophys Res Commun (2001) 0.90

NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site. Biopolymers (2009) 0.87

Functional diversity of anti-lipopolysaccharide factor isoforms in shrimp and their characters related to antiviral activity. Mar Drugs (2015) 0.84

Localization of anti-lipopolysaccharide factor (ALFPm3) in tissues of the black tiger shrimp, Penaeus monodon, and characterization of its binding properties. Dev Comp Immunol (2008) 0.83

Characterization and function analysis of an anti-lipopolysaccharide factor (ALF) from the Chinese shrimp Fenneropenaeus chinensis. Dev Comp Immunol (2014) 0.83

Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution. Ann Clin Microbiol Antimicrob (2011) 0.82

In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin. Sci Rep (2015) 0.80

Rationally designed α-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity. Macromol Rapid Commun (2012) 0.79

Effect of the anti-lipopolysaccharide factor isoform 3 (ALFPm3) from Penaeus monodon on Vibrio harveyi cells. Dev Comp Immunol (2012) 0.78

A defensin from clam Venerupis philippinarum: Molecular characterization, localization, antibacterial activity, and mechanism of action. Dev Comp Immunol (2015) 0.78

Recombinant expression and functional analysis of an isoform of anti-lipopolysaccharide factors (FcALF5) from Chinese shrimp Fenneropenaeus chinensis. Dev Comp Immunol (2015) 0.77

Bidesmosidic triterpenoidal saponins from the roots of Symphytum officinale. Planta Med (1995) 0.76